Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 962918Generated: October 25, 2026

Hydrochloric Acid → Aminophenazone hydrochloride

https://huagongshe.com/reaction/962918

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrochloric AcidHCID 313—
Reactant4-AminoantipyrineHCID 2151—
ReactantAminopyrineHCID 6009—
ReactantAcetonitrileHCID 6342—
ReactantMethylaminoantipyrineHCID 10618—
Reactant4-(Formylamino)antipyrineHCID 72666—
Reactant3-HydroxymethylaminopyrineHCID 3082031—
Reactant4-Formylamino-2-methyl1-phenyl-3-pyrazolin-5-oneHCID 18913459—
Reactant2,3-Dimethyl-4-hydroxyamino-1-phenyl-3-pyrazolin-5-oneHCID 18913460—
Reactant4-Formylamino-3-hydroxymethyl-2methyl-1-phenyl-3-pyrazolin-5-oneHCID 18913461—
SolventWaterHCID 962—
SolventDiethyl EtherHCID 3283—
ProductAminophenazone hydrochlorideHCID 18913462—

Reaction Steps

Aminopyrine hydrochloride was prepared from the free base (Aldrich) by treatment with HCl in ether. lodosobenzene (1650 mg, 7.5 mmol, prepared according to the method of Saltzman et al., Org. Synth., 43:60-61 (1963)) was added with stirring at room temperature in portions every 30 min to a solution of octachloro-octachloro tetrasulfonato Fe(III) porphyrin (6.2 mg 3.9 μmol) in 50 ml of 80:20 H2O:CH3CN containing 678 mg (3.0 mmol) of aminopyrine. Two hr after the last addition of the oxidant, the solution was evaporated under reduced pressure at 50° C. The residue was dissolved in 20 ml of aqueous Na2CO3 solution, and the solution was extracted with CH2Cl2 (3×50 ml). The organic layer was dried over Na2CO3 and evaporated under reduced pressure. The residue was chromatographed on silica gel, eluting with 1:25 methanol:methylene chloride. Seven oxidation products were obtained from the eluate (see Scheme 2): 2,3-dimethyl-4-monomethylamino-1-phenyl-3-pyrazolin5-one (AP-1); 4-amino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one (AP-2); 4formylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one (AP-3); 2,3-dimethyl-4hydroxyamino-1-phenyl-3-pyrazolin-5-one (AP-4); 4-dimethylamino-3hydroxymethyl-2-methyl-1-phenyl-3-pyrazolin-5-one (AP-5); 4-dimethylamino-2,3-dimethyl-1-phenyl-3-pyrazolin-5-one-4-oxide (AP-6); and 4-dimethyl-2,3dimethyl-1-(4-hydroxyphenyl)-3-pyrazolin-5-one (AP-7), 4-formylamino-2-methyl1-phenyl-3-pyrazolin-5-one (AP-8), and 4-formylamino-3-hydroxymethyl-2methyl-1-phenyl-3-pyrazolin-5-one (AP-9).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05760216
Source datasetuspto-grants-1998_06
ORD IDord-71c73e3a87404acf82e5763a8c983f19
Source noteuspto-grants-1998_06